Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2022 pay slips 7% to $6.1M
Kiniksa Pharmaceuticals, Ltd. reports 2022 executive compensation
By ExecPay News
Published: April 27, 2023
Kiniksa Pharmaceuticals, Ltd. reported fiscal year 2022 executive compensation information on April 27, 2023.
In 2022, three executives at Kiniksa Pharmaceuticals, Ltd. received on average a compensation package of $3.3M, a 23% decrease compared to previous year.
Average pay of disclosed executives at Kiniksa Pharmaceuticals, Ltd.
Sanj K. Patel, Chief Executive Officer, received $6.1M in total, which decreased by 7% compared to 2021. 61% of Patel's compensation, or $3.7M, was in option awards. Patel also received $597K in non-equity incentive plan, $835K in salary, $922K in stock awards, as well as $12K in other compensation.
John F. Paolini, Chief Medical Officer, received a compensation package of $1.9M, which decreased by 5% compared to previous year. 49% of the compensation package, or $936K, was in option awards.
Eben Tessari, Chief Operating Officer, earned $1.9M in 2022.
Related executives
You may also like
Source: SEC filing on April 27, 2023.